Ruifang Li-Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ruifang Li-Gao has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
Dennis O. Mook-Kanamori
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands
40 shared publicationsRenée de Mutsert
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
37 shared publicationsTerho Lehtimäki
25 shared publicationsFrits R. Rosendaal
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
24 shared publications- Mika Kähönen
Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland
22 shared publications - Albert Vernon Smith
University of Michigan
20 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Wiley in Maternal & Child Nutrition
- Vol. 22 (4) , e70266
Microbial Imprints of Gestational Diabetes Mellitus: Longitudinal Shifts in Breast Milk, Areola Skin, and Infant Gut
Gestational diabetes mellitus (GDM) has been associated with alterations in maternal and infant gut microbiota. However, it remains unclear whether these associations extend to other maternal‐infant microbial niches and persist during early infancy. This study aimed to characterise longitudinal associations between GDM and microbiota across human milk, areolar skin, and infant faecal niches during early life. We followed 104 mother‐infant pairs (52 GDM and 52 controls) from delivery through 6 months postpartum. Human milk, areolar skin, and infant faecal samples were collected at 1, 4, and 6 months postpartum and profiled using 16S rRNA gene sequencing. Longitudinal associations were evaluated using mixed‐effects models, permutational multivariate analysis of variance, and Spearman correlation. GDM was associated with differences in maternal and infant microbiota across all three niches. Reduced alpha diversity was observed in areolar skin, whereas significant GDM‐by‐time interactions were identified in human milk and infant faecal microbiota. Beta‐diversity analyses revealed persistent differences in microbial community composition. At the genus level, GDM was associated with enrichment of Staphylococcus and temporal changes in Stenotrophomonas in human milk, decreases in Rothia in areolar skin, and an increase in Staphylococcus in infant faeces. Significant associations were also observed between several GDM‐related maternal taxa and corresponding infant faecal taxa. In conclusion, GDM was associated with persistent and niche‐specific microbial differences across interconnected maternal‐infant microbial niches during early life. These findings provide new insights into maternal‐infant microbiota in the context of GDM and support future mechanistic investigations.
- 21 October 2026
- Published by Wiley in Maternal & Child Nutrition
- Vol. 22 (4) , e70266
Open AccessMicrobial Imprints of Gestational Diabetes Mellitus: Longitudinal Shifts in Breast Milk, Areola Skin, and Infant Gut
Gestational diabetes mellitus (GDM) has been associated with alterations in maternal and infant gut microbiota. However, it remains unclear whether these associations extend to other maternal‐infant microbial niches and persist during early infancy. This study aimed to characterise longitudinal associations between GDM and microbiota across human milk, areolar skin, and infant faecal niches during early life. We followed 104 mother‐infant pairs (52 GDM and 52 controls) from delivery through 6 months postpartum. Human milk, areolar skin, and infant faecal samples were collected at 1, 4, and 6 months postpartum and profiled using 16S rRNA gene sequencing. Longitudinal associations were evaluated using mixed‐effects models, permutational multivariate analysis of variance, and Spearman correlation. GDM was associated with differences in maternal and infant microbiota across all three niches. Reduced alpha diversity was observed in areolar skin, whereas significant GDM‐by‐time interactions were identified in human milk and infant faecal microbiota. Beta‐diversity analyses revealed persistent differences in microbial community composition. At the genus level, GDM was associated with enrichment of Staphylococcus and temporal changes in Stenotrophomonas in human milk, decreases in Rothia in areolar skin, and an increase in Staphylococcus in infant faeces. Significant associations were also observed between several GDM‐related maternal taxa and corresponding infant faecal taxa. In conclusion, GDM was associated with persistent and niche‐specific microbial differences across interconnected maternal‐infant microbial niches during early life. These findings provide new insights into maternal‐infant microbiota in the context of GDM and support future mechanistic investigations.
- 15 October 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
Prior Venous Thromboembolism Defines Distinct Genetic and Molecular Phenotypes in Chronic Thromboembolic Pulmonary Hypertension
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) has traditionally been considered a long-term complication of pulmonary embolism. However, a substantial proportion of patients have no history of venous thromboembolism (VTE), suggesting underlying biological heterogeneity. METHODS: We analyzed clinical and imaging characteristics of 712 patients with CTEPH stratified by prior VTE history. Whole-genome sequencing was performed in all patients and 2952 healthy controls to assess common variants. Bulk RNA sequencing of pulmonary endarterectomy tissues and plasma protein quantification were integrated to identify and validate subgroup-specific molecular signatures, with further validation in tissue and primary endothelial cells. RESULTS: Patients with CTEPH and prior VTE (n=576, 80.9%) exhibited a distinct thrombotic phenotype with more proximal disease distribution (92.5% versus 66.2%) and greater likelihood of undergoing pulmonary endarterectomy (22.6% versus 3.7%). Genome-wide association study in CTEPH-VTE(+) patients versus controls identified coagulation-related loci at ABO (rs676996, P =1.1×10 –9 ) and FGG (rs7681423, P =2.5×10 –8 ), with high genetic correlation with pulmonary embolism (rg=0.52, P =0.028). In contrast, no consistent genomic signal was identified in patients without prior VTE. Integrative multiomics (transcriptome-wide association study, MAGMA, and bulk RNA sequencing differential expression analysis) convergently prioritized CTSS (cathepsin S) as a key molecular candidate in CTEPH-VTE(+). CTSS was consistently elevated in plasma, pulmonary endarterectomy tissue, and primary endothelial cells from CTEPH-VTE(+) patients and promoted endothelial proliferation via ERK signaling, which was attenuated by the selective CTSS inhibitor LY3000328. CONCLUSIONS: Stratification by prior VTE history reveals biologically distinct CTEPH phenotypes with divergent genetic architectures and identifies cathepsin S as a genetically nominated therapeutic target for thrombosis-associated pulmonary vascular remodeling.
- 15 October 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
Prior Venous Thromboembolism Defines Distinct Genetic and Molecular Phenotypes in Chronic Thromboembolic Pulmonary Hypertension
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) has traditionally been considered a long-term complication of pulmonary embolism. However, a substantial proportion of patients have no history of venous thromboembolism (VTE), suggesting underlying biological heterogeneity. METHODS: We analyzed clinical and imaging characteristics of 712 patients with CTEPH stratified by prior VTE history. Whole-genome sequencing was performed in all patients and 2952 healthy controls to assess common variants. Bulk RNA sequencing of pulmonary endarterectomy tissues and plasma protein quantification were integrated to identify and validate subgroup-specific molecular signatures, with further validation in tissue and primary endothelial cells. RESULTS: Patients with CTEPH and prior VTE (n=576, 80.9%) exhibited a distinct thrombotic phenotype with more proximal disease distribution (92.5% versus 66.2%) and greater likelihood of undergoing pulmonary endarterectomy (22.6% versus 3.7%). Genome-wide association study in CTEPH-VTE(+) patients versus controls identified coagulation-related loci at ABO (rs676996, P =1.1×10 –9 ) and FGG (rs7681423, P =2.5×10 –8 ), with high genetic correlation with pulmonary embolism (rg=0.52, P =0.028). In contrast, no consistent genomic signal was identified in patients without prior VTE. Integrative multiomics (transcriptome-wide association study, MAGMA, and bulk RNA sequencing differential expression analysis) convergently prioritized CTSS (cathepsin S) as a key molecular candidate in CTEPH-VTE(+). CTSS was consistently elevated in plasma, pulmonary endarterectomy tissue, and primary endothelial cells from CTEPH-VTE(+) patients and promoted endothelial proliferation via ERK signaling, which was attenuated by the selective CTSS inhibitor LY3000328. CONCLUSIONS: Stratification by prior VTE history reveals biologically distinct CTEPH phenotypes with divergent genetic architectures and identifies cathepsin S as a genetically nominated therapeutic target for thrombosis-associated pulmonary vascular remodeling.
- 29 September 2026
- Published by Elsevier in Ophthalmology
Cholesteryl Ester Transfer Protein Inhibition and Risk of Age-Related Macular Degeneration
- 29 September 2026
- Published by Elsevier in Ophthalmology
Cholesteryl Ester Transfer Protein Inhibition and Risk of Age-Related Macular Degeneration
- 29 July 2026
- Published by Elsevier in Metabolism
- Vol. 183, 156719
Reply to letter to the editor: From metabolic subtypes to preventive decisions in high-risk type 2 diabetes
- 29 July 2026
- Published by Elsevier in Metabolism
- Vol. 183, 156719
Reply to letter to the editor: From metabolic subtypes to preventive decisions in high-risk type 2 diabetes
- Open Access
- 1 July 2026
- Published by Elsevier in Metabolism
- Vol. 183, 156687
Pathophysiology-based subtypes of individuals at high risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes
- 1 July 2026
- Published by Elsevier in Metabolism
- Vol. 183, 156687
Open AccessPathophysiology-based subtypes of individuals at high risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes
- Open Access
- 4 April 2026
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1)
The association between liver fat content and plasma metabolite profiles in fasting and postprandial states: an integration of a cohort study and a randomized controlled trial
Postprandial metabolic impairments play a key role in the pathophysiology of cardiometabolic diseases. While liver fat content has been linked to distinct fasting metabolite profiles, its relationship with postprandial metabolite profiles remains unexplored. In this study, we aimed to (1) examine to what extent liver fat content is associated with the postprandial metabolomic profile beyond fasting metabolites; and (2) investigate whether diet-induced changes in liver fat content are associated with changes in plasma metabolites identified in objective 1. In a subpopulation (n = 1986) of an existing cohort study and a 12-week dietary intervention study (n = 80), liver fat content was measured by proton magnetic resonance spectroscopy and categorized as low (< 2.5%), middle (2.5-5.5%), or high (> 5.5%). In the cohort study, plasma metabolomic profiles were quantified by NMR spectroscopy at fasting (T0) and 150 min after a mixed meal (T150). We examined associations between liver fat content and plasma metabolites at T0, T150 and postprandial response (ΔT150-T0) using multivariate linear regression. In the intervention study, plasma metabolomic profiles were quantified at fasting (T0) and at multiple postprandial time points (120, 240, and 360 min) following a mixed meal, both before and after the intervention. We further examined associations between liver fat content and plasma metabolites at T0, and postprandial response (incremental area under the curves [iAUCs]) and explored associations between diet-induced changes in liver fat content and changes in identified metabolites at fasting and postprandial responses (iAUCs). High liver fat group was characterized by higher fasting and postprandial levels of triglycerides, all VLDL and the small LDL/HDL subclasses, ApoB, fatty acids, glycoprotein acetyls, and BCAAs, and lower medium/larger HDL subclasses, and acetate compared to the low liver fat group. In the high vs. low liver fat group, postprandial responses of cholesterol content of S-LDL, IDL, and S-HDL, glutamine and histidine, omega-3% and DHA % were lower. Diet-induced reductions in liver fat were associated with reductions in 40 fasting plasma metabolites, including VLDL-TG, tyrosine, isoleucine, fatty acid ratios, and most of the VLDL subclasses. Postprandial metabolomic profiling revealed additional associations between liver fat content and plasma metabolites beyond fasting measures, particularly in lipoprotein cholesterol and fatty acid composition. Diet-induced reductions in liver fat were associated with favorable changes in fasting metabolites, but not postprandial metabolite responses. Future studies with harmonized postprandial assessment are needed to further elucidate the postprandial observations and the underlying mechanisms. The trials in this study were registered at clinicaltrials.gov as NL21981.058.08/P08.109 and NCT02194504.
- 4 April 2026
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1)
Open AccessThe association between liver fat content and plasma metabolite profiles in fasting and postprandial states: an integration of a cohort study and a randomized controlled trial
Postprandial metabolic impairments play a key role in the pathophysiology of cardiometabolic diseases. While liver fat content has been linked to distinct fasting metabolite profiles, its relationship with postprandial metabolite profiles remains unexplored. In this study, we aimed to (1) examine to what extent liver fat content is associated with the postprandial metabolomic profile beyond fasting metabolites; and (2) investigate whether diet-induced changes in liver fat content are associated with changes in plasma metabolites identified in objective 1. In a subpopulation (n = 1986) of an existing cohort study and a 12-week dietary intervention study (n = 80), liver fat content was measured by proton magnetic resonance spectroscopy and categorized as low (< 2.5%), middle (2.5-5.5%), or high (> 5.5%). In the cohort study, plasma metabolomic profiles were quantified by NMR spectroscopy at fasting (T0) and 150 min after a mixed meal (T150). We examined associations between liver fat content and plasma metabolites at T0, T150 and postprandial response (ΔT150-T0) using multivariate linear regression. In the intervention study, plasma metabolomic profiles were quantified at fasting (T0) and at multiple postprandial time points (120, 240, and 360 min) following a mixed meal, both before and after the intervention. We further examined associations between liver fat content and plasma metabolites at T0, and postprandial response (incremental area under the curves [iAUCs]) and explored associations between diet-induced changes in liver fat content and changes in identified metabolites at fasting and postprandial responses (iAUCs). High liver fat group was characterized by higher fasting and postprandial levels of triglycerides, all VLDL and the small LDL/HDL subclasses, ApoB, fatty acids, glycoprotein acetyls, and BCAAs, and lower medium/larger HDL subclasses, and acetate compared to the low liver fat group. In the high vs. low liver fat group, postprandial responses of cholesterol content of S-LDL, IDL, and S-HDL, glutamine and histidine, omega-3% and DHA % were lower. Diet-induced reductions in liver fat were associated with reductions in 40 fasting plasma metabolites, including VLDL-TG, tyrosine, isoleucine, fatty acid ratios, and most of the VLDL subclasses. Postprandial metabolomic profiling revealed additional associations between liver fat content and plasma metabolites beyond fasting measures, particularly in lipoprotein cholesterol and fatty acid composition. Diet-induced reductions in liver fat were associated with favorable changes in fasting metabolites, but not postprandial metabolite responses. Future studies with harmonized postprandial assessment are needed to further elucidate the postprandial observations and the underlying mechanisms. The trials in this study were registered at clinicaltrials.gov as NL21981.058.08/P08.109 and NCT02194504.
- Open Access
Multi-Omics characterization of biological pathways linking healthy dietary patterns to cardiometabolic disease risk across diverse populations
Background and Objectives: Recent large-scale studies have consistently linked healthy dietary patterns to improved cardiometabolic health; however, the underlying biological pathways remain largely unclear, especially in non-European populations. In this study, we leverage data from four population-based cohorts (UK Biobank, NEO study, GNHS, and 10K) to investigate both common and cohort-specific biological pathways linking healthy dietary patterns to cardiometabolic disease through multi-omics profiling. Material and methods: In each cohort, we first assessed the associations between each of the five major dietary pattern scores (i.e., AMED, hPDI, DII, AHEI, and EDIH) and cardiometabolic disease risk using Cox or logistic regression models. To explore the potential mediating role, metabolomics and proteomics measurements were incorporated into the models. All models were adjusted for relevant confounders, and false discovery rate correction was applied to account for multiple testing. Results: With a total of 71,679 individuals without pre-existing cardiometabolic disease across four participating cohorts (UKB: 54,024, NEO: 4,838, GNHS: 3,201, and 10K: 9,616), we confirmed that adherence to healthy dietary patterns was associated with a 5-10% reduced risk of cardiometabolic disease. Three common biological pathways were identified: (1) mediation via large HDL particles and apolipoprotein F; (2) mediation via DNAJ/Hsp40 and triglyceride-rich lipoproteins; and (3) mediation via CRHBP-regulated HPA axis activity affecting triglyceride-rich lipoproteins. Conclusions: Our integrative multi-omics analysis across diverse populations identifies novel biomarkers that connect healthy dietary patterns with cardiometabolic risk. These findings deepen our understanding of the biological mechanisms underlying diet-related disease and hold promise for enhancing the development of precision nutrition interventions.
Open AccessMulti-Omics characterization of biological pathways linking healthy dietary patterns to cardiometabolic disease risk across diverse populations
Background and Objectives: Recent large-scale studies have consistently linked healthy dietary patterns to improved cardiometabolic health; however, the underlying biological pathways remain largely unclear, especially in non-European populations. In this study, we leverage data from four population-based cohorts (UK Biobank, NEO study, GNHS, and 10K) to investigate both common and cohort-specific biological pathways linking healthy dietary patterns to cardiometabolic disease through multi-omics profiling. Material and methods: In each cohort, we first assessed the associations between each of the five major dietary pattern scores (i.e., AMED, hPDI, DII, AHEI, and EDIH) and cardiometabolic disease risk using Cox or logistic regression models. To explore the potential mediating role, metabolomics and proteomics measurements were incorporated into the models. All models were adjusted for relevant confounders, and false discovery rate correction was applied to account for multiple testing. Results: With a total of 71,679 individuals without pre-existing cardiometabolic disease across four participating cohorts (UKB: 54,024, NEO: 4,838, GNHS: 3,201, and 10K: 9,616), we confirmed that adherence to healthy dietary patterns was associated with a 5-10% reduced risk of cardiometabolic disease. Three common biological pathways were identified: (1) mediation via large HDL particles and apolipoprotein F; (2) mediation via DNAJ/Hsp40 and triglyceride-rich lipoproteins; and (3) mediation via CRHBP-regulated HPA axis activity affecting triglyceride-rich lipoproteins. Conclusions: Our integrative multi-omics analysis across diverse populations identifies novel biomarkers that connect healthy dietary patterns with cardiometabolic risk. These findings deepen our understanding of the biological mechanisms underlying diet-related disease and hold promise for enhancing the development of precision nutrition interventions.
- Open Access
- 1 February 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (2) , e323515
Association Between High-Density Lipoprotein Characteristics and Hemostatic Parameters in the Netherlands Epidemiology of Obesity (NEO) Study—Brief Report
BACKGROUND: Recent evidence points to connections between HDLs (high-density lipoproteins), the coagulation system, and venous thromboembolism occurrence. However, uncertainty remains regarding the impact of specific HDL characteristics on the coagulation system. This study investigated associations between HDL characteristics and hemostatic parameters in a large middle-aged Dutch population. METHODS: Using baseline measurements from 6245 participants in NEO study (the Netherlands Epidemiology of Obesity), we performed adjusted linear regression analyses to estimate associations between 34 parameters of XLHDL (very large HDL), LHDL (large HDL), MHDL (medium HDL), and SHDL (small HDL) particles, as well as ApoA1 (apolipoprotein A1), quantified using a high-throughput 1 H-nuclear magnetic resonance metabolomics platform, and coagulation parameters. These included coagulation factor (F) VIII, FIX, FXI, and fibrinogen, along with 5 parameters of the thrombin generation potential. In addition, the associations between HDL characteristics and parameters of platelet activation and endothelial glycocalyx health were tested in a subpopulation. RESULTS: Our findings revealed a particle size–dependent association between HDL parameters and coagulation parameters. Particularly, per 1-SD increase in the levels of components within XLHDL (very large HDL), we observed lower levels in FIX and FXI activities, endogenous thrombin potential, and peak height (median β [interquartile range], FIX: 3.26% [−3.50% to −3.18%]; FXI: −0.96% [−1.21% to −0.89%]; endogenous thrombin potential: −22.11 [−27.07 to −21.47] nmol/L·min; and peak height: −2.28 [−2.70 to −2.19] nmol/L), indicating an antithrombotic effect. In contrast, per 1-SD increase in the levels of components within MHDL and SHDL, we observed an increase in endogenous thrombin potential, peak height, and activities of FVIII, FIX, and FXI, indicating a prothrombotic effect. HDL characteristics were not associated with platelet activation parameters or with glycocalyx-related parameters. CONCLUSIONS: Our study provides evidence for a size-dependent relationship between HDL components and coagulation parameters. These findings contribute to a better understanding of the potential role of HDL in the pathogenesis of venous thromboembolism.
- 1 February 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (2) , e323515
Open AccessAssociation Between High-Density Lipoprotein Characteristics and Hemostatic Parameters in the Netherlands Epidemiology of Obesity (NEO) Study—Brief Report
BACKGROUND: Recent evidence points to connections between HDLs (high-density lipoproteins), the coagulation system, and venous thromboembolism occurrence. However, uncertainty remains regarding the impact of specific HDL characteristics on the coagulation system. This study investigated associations between HDL characteristics and hemostatic parameters in a large middle-aged Dutch population. METHODS: Using baseline measurements from 6245 participants in NEO study (the Netherlands Epidemiology of Obesity), we performed adjusted linear regression analyses to estimate associations between 34 parameters of XLHDL (very large HDL), LHDL (large HDL), MHDL (medium HDL), and SHDL (small HDL) particles, as well as ApoA1 (apolipoprotein A1), quantified using a high-throughput 1 H-nuclear magnetic resonance metabolomics platform, and coagulation parameters. These included coagulation factor (F) VIII, FIX, FXI, and fibrinogen, along with 5 parameters of the thrombin generation potential. In addition, the associations between HDL characteristics and parameters of platelet activation and endothelial glycocalyx health were tested in a subpopulation. RESULTS: Our findings revealed a particle size–dependent association between HDL parameters and coagulation parameters. Particularly, per 1-SD increase in the levels of components within XLHDL (very large HDL), we observed lower levels in FIX and FXI activities, endogenous thrombin potential, and peak height (median β [interquartile range], FIX: 3.26% [−3.50% to −3.18%]; FXI: −0.96% [−1.21% to −0.89%]; endogenous thrombin potential: −22.11 [−27.07 to −21.47] nmol/L·min; and peak height: −2.28 [−2.70 to −2.19] nmol/L), indicating an antithrombotic effect. In contrast, per 1-SD increase in the levels of components within MHDL and SHDL, we observed an increase in endogenous thrombin potential, peak height, and activities of FVIII, FIX, and FXI, indicating a prothrombotic effect. HDL characteristics were not associated with platelet activation parameters or with glycocalyx-related parameters. CONCLUSIONS: Our study provides evidence for a size-dependent relationship between HDL components and coagulation parameters. These findings contribute to a better understanding of the potential role of HDL in the pathogenesis of venous thromboembolism.
- Open Access
- 13 January 2026
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 133, 106285
Symptomatology of depression and onset of cardiometabolic diseases − A 7-year follow-up study
- 13 January 2026
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 133, 106285
Open AccessSymptomatology of depression and onset of cardiometabolic diseases − A 7-year follow-up study
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (9) , 1693-1703
Plasma N -Glycan Signatures Are Associated With a First Event of Venous Thromboembolism
BACKGROUND: Coagulation factors play important roles in the pathophysiology of venous thromboembolism (VTE), and most of them are glycoproteins, that is, proteins containing glycans attached. Although the connection between glycosylation and coagulation factors seems obvious, the association between glycosylation and VTE risk remains unexplored. We aimed to elucidate the association between N -glycans in plasma and VTE risk in the MEGA study (Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis), a case-control study aiming to identify risk factors for VTE. METHODS: The total plasma N -glycomes of 491 VTE cases with a first idiopathic VTE and 472 controls were analyzed using a robust mass spectrometry platform. In total, 91 N -glycans were measured. The association between each N -glycan and the risk of a first VTE was analyzed with logistic regression models, adjusted for potential confounders. In addition, we also examined the associations between VTE-associated N -glycans as well as glycosylation features and VTE-associated coagulation factors with linear regression models. RESULTS: In the analysis, 466 idiopathic VTE cases and 454 controls were included. We found that fucosylation of complex-type glycans and the presence of more antennae in glycan structures were associated with an increased risk of VTE. Conversely, monoantennary and diantennary complex–type glycans, as well as oligomannose-type glycans, were associated with a reduced risk of VTE. The associations between glycan features and VTE risk were partially supported by their relationships with procoagulant factors. CONCLUSIONS: We demonstrated the relevance of plasma N -glycan signatures in the risk of a first VTE. Plasma N -glycome holds a strong potential for VTE risk stratification.
- 1 September 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (9) , 1693-1703
Open AccessPlasma N -Glycan Signatures Are Associated With a First Event of Venous Thromboembolism
BACKGROUND: Coagulation factors play important roles in the pathophysiology of venous thromboembolism (VTE), and most of them are glycoproteins, that is, proteins containing glycans attached. Although the connection between glycosylation and coagulation factors seems obvious, the association between glycosylation and VTE risk remains unexplored. We aimed to elucidate the association between N -glycans in plasma and VTE risk in the MEGA study (Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis), a case-control study aiming to identify risk factors for VTE. METHODS: The total plasma N -glycomes of 491 VTE cases with a first idiopathic VTE and 472 controls were analyzed using a robust mass spectrometry platform. In total, 91 N -glycans were measured. The association between each N -glycan and the risk of a first VTE was analyzed with logistic regression models, adjusted for potential confounders. In addition, we also examined the associations between VTE-associated N -glycans as well as glycosylation features and VTE-associated coagulation factors with linear regression models. RESULTS: In the analysis, 466 idiopathic VTE cases and 454 controls were included. We found that fucosylation of complex-type glycans and the presence of more antennae in glycan structures were associated with an increased risk of VTE. Conversely, monoantennary and diantennary complex–type glycans, as well as oligomannose-type glycans, were associated with a reduced risk of VTE. The associations between glycan features and VTE risk were partially supported by their relationships with procoagulant factors. CONCLUSIONS: We demonstrated the relevance of plasma N -glycan signatures in the risk of a first VTE. Plasma N -glycome holds a strong potential for VTE risk stratification.